Navigation Links
Leading HIV researchers to collaborate on vaccine development
Date:4/15/2008

do not develop AIDS

  • Development of standardized methods to sample tissues from mucosal surfaces in the body, where HIV initially establishes infection.

    Investigators supported by both organizations are especially interested in further understanding what happens in the very earliest post-infection stage of HIV infection, especially within the bodys T cells, a class of white blood cells that normally fight off foreign invaders like bacteria and viruses. One of the goals of this work will be to identify any genetic variations linked to the strength of the immune response at the site of initial infection. CHAVI and IAVI hope that by sharing samples, reagents, databases and laboratories and by launching parallel studies, they will be able to speed up discoveries about this critical phase of the disease.

    Each partner to the agreement will contribute unique resources. For example, CHAVI supports high-throughput sequencing technology that can reveal tiny mutations in the ever-changing virus, but which require large numbers of HIV samples in order to identify variations that are meaningful. Through its network of clinical research centers and immunological laboratories around the world, IAVI and its partners have developed a number of tests to evaluate human immune responses to HIV and to potential vaccine candidates, information that can help researchers refine and improve any candidate that shows promise. By pooling technologies, protocols and access to samples, the IAVI/CHAVI collaboration aims to extract maximum information to help accelerate the development of a safe and effective AIDS vaccine.

    As an African clinical investigator and the leader of the scientific steering committee that oversees the IAVI-supported study of acute HIV infection, I am pleased to be collaborating with IAVI and CHAVI. It is critical to investigate the influence of genetic diversity of HIV as well as the variety of human immune responses to HIV
    '/>"/>


  • Contact: Michelle Gailiun
    michelle.gailiun@duke.edu
    919-684-4148
    Duke University Medical Center
    Source:Eurekalert

    Page: 1 2 3

    Related medicine news :

    1. Leading experts investigate Shaken Baby Syndrome
    2. Unstable Economy Leading to Executive Stress
    3. Leading Life Sciences Company Installs SafeMedias Network Security Management Appliance to Prevent Illegal Peer to Peer (P2P) File Sharing
    4. Fifth Third Bank Teams with Leading Healthcare Providers to Deliver a Claims-to-Payment Business Intelligence Platform
    5. Europes Leading Premium Appliance Brand Taps Americas Most Stylish, Multi-Tasking Mom to Launch New Appliance Line in North America
    6. Comfort C(R) Provides Significantly Higher Absorption Than Other Leading Brand
    7. New Welsh Self-Test to Cure Glaucoma, the Leading Cause of Preventable Blindness
    8. Leading Epilepsy Advocates Propose Strategies to Heighten Treatment Expectations and Close Patient and Physician Communication Gaps
    9. AutismOnline.org Partners With Leading Health Communications Firm for Support
    10. NYU dental researchers find evidence of periodontal disease leading to gestational diabetes
    11. Leading Health Groups Applaud Continued Efforts to Protect Public Health by Ending So-Called Theatrical Productions in Bars
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/29/2015)... New York, NY (PRWEB) , ... August 29, ... ... consistently successful results and include treating the localized area with stretching, soft tissue ... and a neutral pelvic position have shown through research to improve treatment ...
    (Date:8/28/2015)... ... 2015 , ... Rio Salado College joined nine educational institutions in ... of the EDUCAUSE - Next Generation Learning Challenges 2015 Breakthrough Models Incubator funded by ... Breakthrough Models Incubator hosted by EDUCAUSE and NGLC, which is designed to bring ...
    (Date:8/28/2015)... (PRWEB) , ... August 28, 2015 , ... ... No Malaria Day at the Zoo to celebrate children helping children, a thank ... their congregations throughout West Ohio have contributed to the United Methodist initiative to ...
    (Date:8/28/2015)... ... , ... With the goal of furthering music education programs in schools, the ... County Fairgrounds in Mendon, IL on May 30th, 2015. Backed once again by Best ... the underfunded school districts of Mendon and its neighboring town of Quincy, IL. Best ...
    (Date:8/28/2015)... ... ... As reported by Medical Daily on August 22 , Cellfina, a ... for two years, the longest of any cellulite reduction system currently on the market. ... effective solution for their cellulite, according to Dr. Robert Weiss, director of the premier ...
    Breaking Medicine News(10 mins):Health News:NEW APPROACH for Treatment of Recurrent Hamstring Strains and Hamstring Tendinosis is Available for the First Time in NYC 2Health News:NEW APPROACH for Treatment of Recurrent Hamstring Strains and Hamstring Tendinosis is Available for the First Time in NYC 3Health News:Rio Salado College Joins 9 Educational Leaders to Reinvent Higher Learning 2Health News:Rio Salado College Joins 9 Educational Leaders to Reinvent Higher Learning 3Health News:Rio Salado College Joins 9 Educational Leaders to Reinvent Higher Learning 4Health News:Saturday’s United Methodist Event at Columbus Zoo Celebrates Imagine No Malaria 2Health News:Saturday’s United Methodist Event at Columbus Zoo Celebrates Imagine No Malaria 3Health News:Best Drug Rehabilitation Interviews Country-Rock Duo Highway Run at the 2015 "Music With A Mission" Benefit Concert 2Health News:Maryland Dermatologists Discuss Non-Invasive Cellulite Reduction System Cellfina Receiving 2-Year FDA Clearance 2Health News:Maryland Dermatologists Discuss Non-Invasive Cellulite Reduction System Cellfina Receiving 2-Year FDA Clearance 3
    ... , THURSDAY, Oct. 13 (HealthDay News) -- Human children are ... a new study finds. Researchers compared the responses of ... Republic of Congo sanctuary. Both the children and the ... own or with a partner. Individuals could pull two ends ...
    ... on the Nature review website, provides evidence of ... use of these stem cells to treat humans, through perspective ... to produce cells with stem cell properties, by using specialized ... These ,iPS, stem cells are said to be "pluripotent,: they ...
    ... the International Osteoporosis Foundation (IOF) is releasing a 24-page ... strong muscles. Professor Heike Bischoff-Ferrari, director Centre ... City Hospital and author of the report, stated, "Put ... optimize your bone health by following three essential steps." ...
    ... In findings with major implications for the genetics of cancer ... (BIDMC) and two other science teams in New York City ... and showed how it may work to drive cancer and ... in the journal Cell describe aspects of what ...
    ... could help identify the manufacturers of designer ,legal high, drugs ... Strathclyde in Glasgow. The drugs, known by names such ... salts, plant food and incense, mimic the effects of illegal ... ,designer drugs, can be dangerous, many have not yet been ...
    ... , THURSDAY, Oct. 13 (HealthDay News) -- ... have more relationship problems, according to a new study. ... and possessions can take a toll on couples, happiness ... Brigham Young University analyzed relationship evaluations completed by more ...
    Cached Medicine News:Health News:Young Children Collaborate Better Than Chimps 2Health News:Steps towards the use of adult stem cells for gene therapy 2Health News:Three steps to unbreakable bones on World Osteoporosis Day 2Health News:Researchers discover hidden genetic influence on cancer 2Health News:Researchers discover hidden genetic influence on cancer 3Health News:Researchers discover hidden genetic influence on cancer 4Health News:Researchers discover hidden genetic influence on cancer 5Health News:Tests to catch the makers of dangerous 'legal high' designer drugs 2Health News:Couples Can Pay a Price for Materialism 2
    (Date:8/27/2015)... FRANKLIN, Mass. , Aug. 27, 2015 /PRNewswire/ ... in the KSSTA Knee Journal, compared the Arthrosurface ... "inlay" Arthroplasty design, versus an "onlay" design implant ... showed similar improvements in function and pain scores, ... showed progression of osteoarthritis (OA). However, 53% of ...
    (Date:8/27/2015)... Biosimilars are not generics and the ... and Drug Administration (FDA) for recognizing that each ... guidance issued today. The FDA,s draft guidance on ... calling for biological products to bear a nonproprietary ... reflects the agency,s thinking that "there is a ...
    (Date:8/27/2015)... According to a new market research report "Medical Lifting ... ), Material (Nylon, Padded, Canvas), Usage Type (Disposable, Reusable), End User ... Medical Lifting Sling Market is poised to reach USD 706.0 Million ... of 11.4 % from 2015 to 2020. , ... ables and 65 F igures ...
    Breaking Medicine Technology:Study Demonstrates Dramatic Reduction in Progression of Osteoarthritis with the Arthrosurface "Inlay" Patellofemoral Implant Design Compared to Traditional "Onlay" Implant 2Study Demonstrates Dramatic Reduction in Progression of Osteoarthritis with the Arthrosurface "Inlay" Patellofemoral Implant Design Compared to Traditional "Onlay" Implant 3Biologics Prescribers Collaborative (BPC) Statement on FDA Draft Guidance entitled "Nonproprietary Naming of Biological Products" 2Medical Lifting Sling Market Worth USD 706.0 Million by 2020 2Medical Lifting Sling Market Worth USD 706.0 Million by 2020 3Medical Lifting Sling Market Worth USD 706.0 Million by 2020 4
    ... Bermuda, Dec. 16 Celtic Pharmaceutical Holdings L.P. ("Celtic ... preliminary analyses completed on the two double-blinded studies of XERECEPT ... edema, as well as an initial database lock on the ... , The results of these studies ...
    ... Live Broadcast on December 18, 2008 at 9 a.m. Eastern Time ... MannKind Corporation (Nasdaq: MNKD ) will host ... 3 studies of AFRESA(TM), the company,s ultra rapid acting, inhaled insulin product, ... , , To participate in the live ...
    Cached Medicine Technology:Celtic Pharma Announces Update on Status of XERECEPT(R) Program Sale Planned in 2009 2MannKind Corporation to Review Positive Results From Final Two Pivotal Phase 3 Clinical Studies in Type 1 and Type 2 Diabetes 2
    ... Are Turned 90 Degrees To Allow ... While Incising Tissue. ,Special Mirror-Polished Double Footplate ... Blade Extension Settings Of 0.5mm, 0.55mm, ... Extension.,1mm Wide Snub Nose Diamond Blade ...
    ... Unique In-Line Footplates Are Turned ... Of The Diamond Blade While Incising ... Precise Blade Depth Penetration.,Pre-Set Blade Extension ... Full Retraction And Full Extension.,1mm Wide ...
    ... 23g Tube Allows Use Through A ... More Comfortable Approach To The Incision.,Cystotome ... Capsule To Initiate And Complete A ... Weight For Improved Ergonomic Feel. Ideal ...
    2.5V Halogen source, fiber-optic delivery, 2.5X magnification....
    Medicine Products: